FDI-6 from MedChemExpress

Product Specs
ItemFDI-6
CompanyMedChemExpress
Price $105.00Supplier Page View Company Product Page
Catalog NumberHY-112721
Quantity10 mM * 1 mL
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.65%
TypeChemical
Molecular Weight437.43
FormulaC₁₉H₁₁F₄N₃OS₂
Research AreaCancer

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) LaGrACE: estimating gene program dysregulation with latent regulatory networkMolecular Systems BiologyJune 30, 2025Minxue Jia, Haiyi Mao, Mengli Zhou, Yu-Chih Chen, Panayiotis V Benosassay Compound preparation Dissolve each compound (Thiostrepton (Cayman: 19200), FDI-6 (Medchemexpress, HY-112721), RCM-1 (Medchemexpress, HY-19979)) to a concentration of 10 mM in either DMSO or PBS, following the

(2) Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast CancerCancer ResearchNovember 4, 2024Katrina M. Piemonte, Natasha N. Ingles, Kristen L. Weber-Bonk, Mitchell J. Valentine, Parth R. Majmudar, Salendra Singh, Ruth A. KeriRadnor, PA; S1150), docetaxel (LC Laboratories, Woburn, MA; D-1000), and FDI-6 (FOXM1i, MedChemExpress, HY-112721)were dissolved in DMSO. For in vivo experiments, CH695 (60mg/kg, PO) was dissolved in 40% PEG, 5% Tween 20

(3) FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter regionHeliyonMarch 15, 2024Mengcha Tian, Jiaming Li, Huihui Wu, Yuying Wu(CCK-8) detection kit (Cat. No.: CK-4) was purchased from Dojindo Laboratories, Japan; FDI-6 (Cat. No.: HY-112721) was purchased from MedChemExpress, USA; and an miR-509-5p inhibitor designed by Beijing Qingke Biotechnology

(4) Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma CellsCancersOctober 11, 2022Lee Y, Wu Z, Yang S, Schreiner SM, Gonzalez-Smith LD, Rhie SK.humidified incubator with 5% CO2. 2.3. FDI-6 Treatment FDI-6 was obtained from MedChemExpress (Cat #HY-112721, Monmouth Junction, NJ, USA). For cell proliferation analysis, A549 cells and NCI-H2126 cells were seeded

(5) Suppression of the FOXM1 transcriptional programme via novel small molecule inhibitionNature communicationsNovember 12, 2014Gormally MV, Dexheimer TS, Marsico G, Sanders DA, Lowe C, Matak-Vinković D, Michael S, Jadhav A, Rai G, Maloney DJ, et al.

(6) Death and dying: attitudes of patient and doctor. IV. Studies on attitudes toward deathRep Group Adv PsychiatryOctober 1, 1965Greenberg IM.

Be the First to Write a Review!

Description

MedChemExpress

Citations (6)

Reviews

FDI-6 from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map